Allowed Publications
Slot System
Featured Buckets
Featured Buckets Admin

Can IM Pralidoxime Safely Be Converted to an IV Form?

Article Type
Changed
Display Headline
Can IM Pralidoxime Safely Be Converted to an IV Form?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(6)
Publications
Page Number
13
Legacy Keywords
pralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACKpralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACK
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(6)
Issue
Federal Practitioner - 23(6)
Page Number
13
Page Number
13
Publications
Publications
Article Type
Display Headline
Can IM Pralidoxime Safely Be Converted to an IV Form?
Display Headline
Can IM Pralidoxime Safely Be Converted to an IV Form?
Legacy Keywords
pralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACKpralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACK
Legacy Keywords
pralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACKpralidoxime, intramuscular, converted, intravenous, form, Henretig, technique, CHEMPACK
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

SSRIs and Bleeding Risk

Article Type
Changed
Display Headline
SSRIs and Bleeding Risk

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(6)
Publications
Page Number
13
Legacy Keywords
SSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactionsSSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactions
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(6)
Issue
Federal Practitioner - 23(6)
Page Number
13
Page Number
13
Publications
Publications
Article Type
Display Headline
SSRIs and Bleeding Risk
Display Headline
SSRIs and Bleeding Risk
Legacy Keywords
SSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactionsSSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactions
Legacy Keywords
SSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactionsSSRI, selective, serotonin, reuptake, inhibitors, bleeding, risk, adverse drug effects and interactions
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Redosing Promethazine

Article Type
Changed
Display Headline
Redosing Promethazine

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(5)
Publications
Page Number
40
Legacy Keywords
promethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterologypromethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterology
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(5)
Issue
Federal Practitioner - 23(5)
Page Number
40
Page Number
40
Publications
Publications
Article Type
Display Headline
Redosing Promethazine
Display Headline
Redosing Promethazine
Legacy Keywords
promethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterologypromethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterology
Legacy Keywords
promethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterologypromethazine, antiemetic, nausea, vomiting, sedative, low, dose, allergy, gastroenterology
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Sunitinib: At What Dose Is Toxicity Manageable?

Article Type
Changed
Display Headline
Sunitinib: At What Dose Is Toxicity Manageable?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(5)
Publications
Topics
Page Number
40
Legacy Keywords
sunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effectssunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effects
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(5)
Issue
Federal Practitioner - 23(5)
Page Number
40
Page Number
40
Publications
Publications
Topics
Article Type
Display Headline
Sunitinib: At What Dose Is Toxicity Manageable?
Display Headline
Sunitinib: At What Dose Is Toxicity Manageable?
Legacy Keywords
sunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effectssunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effects
Legacy Keywords
sunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effectssunitinib, toxicity, manageable, dose, tumor, cancer, malignancies, adverse, effects
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Reducing Defibrillator Shocks

Article Type
Changed
Display Headline
Reducing Defibrillator Shocks

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(5)
Publications
Topics
Page Number
39
Legacy Keywords
defibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trialdefibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trial
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(5)
Issue
Federal Practitioner - 23(5)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
Reducing Defibrillator Shocks
Display Headline
Reducing Defibrillator Shocks
Legacy Keywords
defibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trialdefibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trial
Legacy Keywords
defibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trialdefibrillator, reducing, shocks, beta-blocker, amiodarone, sotalol, implantable, cardioverter, ICD, ventricular, risk, Optimal, Pharmacological, Therapy, Patients, OPTIC, trial
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Calming Restless Legs

Article Type
Changed
Display Headline
Calming Restless Legs

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(5)
Publications
Topics
Page Number
39
Legacy Keywords
primary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, studyprimary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, study
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(5)
Issue
Federal Practitioner - 23(5)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
Calming Restless Legs
Display Headline
Calming Restless Legs
Legacy Keywords
primary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, studyprimary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, study
Legacy Keywords
primary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, studyprimary, restless, legs, syndrome, RLS, ropinirole, dopamine, sleep, Therapy, Efficacy, Tolerability, TREAT, US, study
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Aspirin Use and Stroke Prognosis

Article Type
Changed
Display Headline
Aspirin Use and Stroke Prognosis

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(4)
Publications
Topics
Page Number
34
Legacy Keywords
spontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematomaspontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematoma
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(4)
Issue
Federal Practitioner - 23(4)
Page Number
34
Page Number
34
Publications
Publications
Topics
Article Type
Display Headline
Aspirin Use and Stroke Prognosis
Display Headline
Aspirin Use and Stroke Prognosis
Legacy Keywords
spontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematomaspontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematoma
Legacy Keywords
spontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematomaspontaneous, intracerebral, hemorrhage, ICH, stroke, aspirin, medication, warfarin, hematoma
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

HIV Treatment: Continuous or Episodic?

Article Type
Changed
Display Headline
HIV Treatment: Continuous or Episodic?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(4)
Publications
Topics
Page Number
34
Legacy Keywords
HIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservationHIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservation
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(4)
Issue
Federal Practitioner - 23(4)
Page Number
34
Page Number
34
Publications
Publications
Topics
Article Type
Display Headline
HIV Treatment: Continuous or Episodic?
Display Headline
HIV Treatment: Continuous or Episodic?
Legacy Keywords
HIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservationHIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservation
Legacy Keywords
HIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservationHIV, continuous, antiretroviral, therapy, SMART, infectious, disease, positive, CD4, ART, DC, drug, conservation
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Who is Susceptible to DDS?

Article Type
Changed
Display Headline
Who is Susceptible to DDS?

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(3)
Publications
Page Number
12
Legacy Keywords
parkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screenparkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screen
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(3)
Issue
Federal Practitioner - 23(3)
Page Number
12
Page Number
12
Publications
Publications
Article Type
Display Headline
Who is Susceptible to DDS?
Display Headline
Who is Susceptible to DDS?
Legacy Keywords
parkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screenparkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screen
Legacy Keywords
parkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screenparkinson, disease, PD, dopamine, dysregulation, syndrome, DDS, impulsive, sensation, seeking, ISS, predispose, questionnaire, trait, compulsive, use, medication, increase, tolerance, screen
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Clopidogrel: When Less is More

Article Type
Changed
Display Headline
Clopidogrel: When Less is More

Article PDF
Author and Disclosure Information

Issue
Federal Practitioner - 23(3)
Publications
Topics
Page Number
12
Legacy Keywords
clopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCIclopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCI
Sections
Author and Disclosure Information

Author and Disclosure Information

Article PDF
Article PDF

Issue
Federal Practitioner - 23(3)
Issue
Federal Practitioner - 23(3)
Page Number
12
Page Number
12
Publications
Publications
Topics
Article Type
Display Headline
Clopidogrel: When Less is More
Display Headline
Clopidogrel: When Less is More
Legacy Keywords
clopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCIclopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCI
Legacy Keywords
clopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCIclopidogrel, dose, loading, intracoronary, stenting, antithrombotic, regimen, ISAR-CHOICE, saturation, platelet, plasma, bottle-neck, antiplatelet, percutaneous, coronary, intervention, PCI
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media